[#DIV28SUPER] Three RFAs from the National Institute on Drug Abuse

NIDA has set aside $2M  for these two extracellular vesicle RFAs

 

• Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R41/R42)
  (RFA-DA-17-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 22, 2016

 

• Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R43/R44)
  (RFA-DA-17-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 22, 2016

-----------------------------------

NIDA has set aside $2M for this RFA. 

 

Silencing of HIV-1 Proviruses (R61/R33)
(RFA-AI-16-038)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): December 7, 2016, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.

This FOA supports high-risk studies to understand how an epigenetic regulatory pathway can be exploited to develop novel small molecule or RNA therapeutics that can be useful for HIV-1 functional cure. 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309